Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

被引：3
作者：
Sheshadri, Ajay [1 ]
Saliba, Rima [2 ]
Patel, Badar [1 ]
Ahmed, Tahreem [1 ]
Bueno, Luis C. [3 ]
Arain, Muhammad H. [1 ]
Mehta, Rohtesh S. [2 ]
Popat, Uday R. [2 ]
Hosing, Chitra M. [2 ]
Rondon, Gabriela [2 ]
Bashoura, Lara [1 ]
Dickey, Burton F. [1 ]
Champlin, Richard E. [2 ]
Alousi, Amin M. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[3] Tecnol Monterrey, Escuela Med & Ciencias Salud, Houston, TX USA
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / 03期
关键词：
BRONCHIOLITIS OBLITERANS SYNDROME; VERSUS-HOST-DISEASE; SURVIVAL;
D O I：
10.1038/s41409-020-01073-0
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
[No abstract available]
引用
收藏
页码：745 / 748
页数：4
相关论文
共 16 条
  • [1] Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients
    Portier, D. A.
    Sabo, R. T.
    Roberts, C. H.
    Fletcher, D. S.
    Meier, J.
    Clark, W. B.
    Neale, M. C.
    Manjili, M. H.
    McCarty, J. M.
    Chung, H. M.
    Toor, A. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 (12) : 1513 - 1519
  • [2] Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation
    Mountjoy, Luke
    Jain, Tania
    Kunze, Katie L.
    Khera, Nandita
    Sproat, Lisa Z.
    Jennifer, Woodburn
    McCallen, Margaret
    Leis, Jose F.
    Noel, Pierre
    Slack, James L.
    Palmer, Jeanne
    LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 1996 - 2002
  • [3] The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies
    Sakellari, Ioanna
    Batsis, Ioannis
    Bousiou, Zoi
    Mallouri, Despina
    Constantinou, Varnavas
    Gavriilaki, Eleni
    Smias, Christos
    Yannaki, Evangelia
    Kaloyannidis, Panayotis
    Papaioannou, Giorgos
    Stavroyianni, Niki
    Syrigou, Antonia
    Sotiropoulos, Damianos
    Fylaktou, Asimina
    Tsompanakou, Aliki
    Saloum, Riad
    Anagnostopoulos, Achilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10) : 658 - 666
  • [4] Discrepancy in the kinetics of total and active anti-thymocyte globulin blood concentrations in recipients of allogeneic hematopoietic stem cell transplantation
    Yamane, Akiko
    Mori, Takehiko
    Kato, Jun
    Ono, Yukako
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 406 - 407
  • [5] Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
    Alousi, Amin M.
    Le-Rademacher, Jennifer
    Saliba, Rima M.
    Appelbaum, Frederick R.
    Artz, Andrew
    Benjamin, Jonathan
    Devine, Steven M.
    Kan, Fangyu
    Laughlin, Mary J.
    Lazarus, Hillard M.
    Liesveld, Jane
    Perales, Miguel-Angel
    Maziarz, Richard T.
    Sabloff, Mitchell
    Waller, Edmund K.
    Eapen, Mary
    Champlin, Richard E.
    BLOOD, 2013, 121 (13) : 2567 - 2573
  • [6] Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji, Young Sok
    Lee, Min Sung
    Min, Chang Wook
    Park, Seong Kyu
    Kim, Se Hyung
    Yun, Jina
    Kim, Hyun Jung
    Kim, Kyoung Ha
    Kim, Chan Kyu
    Lee, Kyu-Taek
    Won, Jong-Ho
    Hong, Dae Sik
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04) : 750 - 761
  • [7] Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
    Seo, Jeongmin
    Shin, Dong-Yeop
    Koh, Youngil
    Kim, Inho
    Yoon, Sung-Soo
    Byun, Ja Min
    Hong, Junshik
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [8] Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation
    Chalchal, Hafsah
    Dhir, Vinita
    Masurekar, Ashish
    Atkins, Harold
    Bredeson, Christopher
    Kennah, Michael
    Kekre, Natasha
    Allan, David
    Nampoothiri, Ram Vasudevan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 543 - 549
  • [9] Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
    Butera, Sara
    Cerrano, Marco
    Brunello, Lucia
    Dellacasa, Chiara Maria
    Faraci, Danilo Giuseppe
    Vassallo, Sara
    Mordini, Nicola
    Sorasio, Roberto
    Zallio, Francesco
    Busca, Alessandro
    Bruno, Benedetto
    Giaccone, Luisa
    ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1837 - 1847
  • [10] Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: A systematic review and meta-analysis
    Tang, Lu
    Liu, Zhigang
    Li, Tao
    Dong, Tian
    Wu, Qiuhui
    Niu, Ting
    Liu, Ting
    Ji, Jie
    FRONTIERS IN ONCOLOGY, 2023, 13
12